Dealbreaker on MSN
Startup Fortitude Bio launches to beat drug resistance in cancer, expand ADCs to autoimmune disease
The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.
Accelerated by the COVID-19 pandemic, research is now exploring vaccines capable not only of preventing infections, but also ...
A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...
A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
This is read by an automated voice. Please report any issues or inconsistencies here. There are more than 100 autoimmune diseases, affecting tens of millions as cases continue to rise, and 4 in 5 ...
Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...
Morning Overview on MSN
Scientists say they have finally cracked the hidden rules of cancer
Cancer has long been portrayed as a disease of pure genetic chaos, a biological roulette that makes every tumor feel uniquely ...
In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the ...
Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results